Latest News

20. February 2023

OPPENLÄNDER provided antitrust advice to Daimler Truck AG

Dr. Christoph Wolf and Dr. Natalie Seitz provided antitrust advice to Daimler Truck AG on the sale of engine licenses and the acquisition of a stake in Cologne-based engine manufacturer Deutz.

27. January 2023

OPPENLÄNDER strengthens antitrust law with new lawyer

Attorney-at-law Christian Geyer joins OPPENLÄNDER's antitrust team around partner Dr. Christoph Wolf as of January 16, 2023.

25. January 2023

OPPENLÄNDER strengthens mobility team with new lawyer

Since 16 January 2023, lawyer Vera Dörrfuß has strengthened OPPENLÄNDER's mobility team around partners Dr. Corina Jürschik and Prof. Dr. Lenz.

19. January 2023

OPPENLÄNDER strengthens health law with new lawyer

Since the beginning of the year, lawyer Pia Koller has strengthened OPPENLÄNDER's health law team, which is led by the three partners Dr. Katharina Köbler, Dr. Timo Kieser and Dr. Christina Koppe-Zagouras.

02. January 2023

OPPENLÄNDER strengthens corporate law with new partner

As of today, Dr. Thomas Kreuz is a new partner at OPPENLÄNDER. We are pleased about the reinforcement by an experienced lawyer.

23. November 2022

Second direct award to Karlsruhe transport company completed

The city of Karlsruhe has placed its local public transport on a new footing by awarding a public service contract directly to its municipal transport company VBK in accordance with Regulation 1370/2007. Dr. Corina Jürschik and Prof. Dr. Christofer Lenz provided advice.

15. November 2022

New associate partner at OPPENLÄNDER

As of today, Dr. Joachim Ott is an associate partner at OPPENLÄNDER.

28. October 2022

ECJ rules on the relationship between antitrust and regulatory law

On 27 October 2022, the ECJ ruled on the relationship and interplay between antitrust and regulatory law in a complex of cases regarding railroad infrastructure pricing and led by Prof. Dr. Markus Köhler and Dr. Malte Weitner.

26. October 2022

What to do in case of an entry in the competition register?

At the Stuttgarter Compliance Talks of the Stuttgarter Zeitung, OPPENLÄNDER partner Dr. Matthias Ulshöfer explained how to avoid an entry and the threat of an award ban.